POPVAX

PopVax is an Indian biotechnology company based in Hyderabad which is building a thermostable, chimeric, low-cost, and safe second-generation mRNA platform for vaccines and therapeutics, starting with room-temperature stable multivariant vaccines to combat current and future strains of SARS-CoV-2, the virus which causes COVID-19... PopVax was founded by Soham Sankaran, and our research work has been funded primarily by the Bill & Melinda Gates Foundation (India). The team includes a former founding employee of Moderna and some of India's top experts in mRNA, lipid nanoparticle (LNP) formulation, and antigen selection from both academia and industry... The name PopVax is a portmanteau of the phrase population-scale vaccines. It represents our commitment to building a platform for cutting-edge vaccine development and production whose benefits are available at the same time to the entire global population, rather than just those lucky enough to live in the moneyed West. In line with..

Also known as: PopVax Private Limited